Astrazeneca Pharma India share price
You have to be logged in to add this to Watchlist.- ₹8,510.80(1.52%)March 21, 2025 15:31:18 PM IST
- NSE
- BSE
- Vol : 74.88K (NSE + BSE)Last 20 day avg : 47.33 K
Astrazeneca Pharma India is trading 1.52% upper at Rs 8,510.80 as compared to its last closing price. Astrazeneca Pharma India has been trading in the price range of 8,699.00 & 8,221.95. Astrazeneca Pharma India has given 14.76% in this year & 8.78% in the last 5 days. Astrazeneca Pharma India has TTM P/E ratio 188.36 as compared to the sector P/E of 30.97.The company posted a net profit of 30.85 Crores in its last quarter.Listed peers of Astrazeneca Pharma India include Aurobindo Pharma (2.19%), Astrazeneca Pharma India (1.52%), Pfizer (0.41%).The Mutual Fund holding in Astrazeneca Pharma India was at 5.04% in 31 Dec 2024. The MF holding has decreased from the last quarter. The FII holding in Astrazeneca Pharma India was at 2.92% in 31 Dec 2024. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Updated on Mar 21, 2025, 03:02 PM UTC
- Dividend YieldLower than industry0.29Annual dividends as a percentage of the stock price.
- P/BHigher than historical values29.44The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values216.16Price-to-earnings ratio based on trailing 12-month earnings
- BetaLow volatility0.54Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- PEG Ratio-The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
- Income
- Balance Sheet
- Cash Flow
- Financial
- Valuation
Company is profitable- The company's revenue grew in December quarter by 43.98% from Rs 440.29 crore to Rs 305.79 crore, year-on-year
- The company has grown its December quarter profit by 95.24% from Rs 15.80 crore to Rs 30.85 crore, year-on-year
- The debt to equity of the company is lower than the industry median
- Company can comfortably pay off its interest obligations with its earnings
- R1
- 7,601.07
- R2
- 8,495.73
- R3
- 8,991.47
- S1
- 6,210.67
- S2
- 5,714.93
- S3
- 4,820.27
- Very Bearish
- Bearish
- Neutral
- Very Bullish
- Bullish
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma | Neutral | 1,200.10 | 2.19 | 69,702.00 | 20.42 | 2.29 | 0.39 | 8.00 |
| Astrazeneca Pharma India | Bullish | 8,510.80 | 1.52 | 21,277.00 | 131.42 | 27.75 | 0.30 | 0.39 |
| Pfizer | Neutral | 4,132.95 | 0.41 | 18,907.31 | 33.98 | 5.18 | 0.86 | 1.51 |
| Neuland Laboratories | Neutral | 11,808.00 | 1.12 | 15,149.53 | 46.36 | 11.5 | 0.12 | 4.22 |
| Unichem Laboratories | Bullish | 707.75 | 6.50 | 4,982.96 | - | 1.96 | - | 2.64 |
- Promoter(s) holds a high stake in the company at 75.00%
- FIIs are invested in this company
- FIIs holding has increased by 0.02 percentage points from previous quarter
Mutual Funds holding has decreased by 0.01 percentage points from previous quarter
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2025-02-11 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
| 2024-05-27 | Audited Results & Dividend |
| 2024-02-08 | Quarterly Results |
- IndustryMajor Drugs
- ISININE203A01020
- BSE Code106820
- NSE CodeASTRAZEN
Astrazeneca Pharma India is trading at 8510.80 as on Fri Mar 21 2025 10:01:18. This is 1.52% upper as compared to its previous closing price of 8383.60.
The market capitalization of Astrazeneca Pharma India is 21277.00 Cr as on Fri Mar 21 2025 10:01:18.
The 52 wk high for Astrazeneca Pharma India is 8877.00 whereas the 52 wk low is 4800.15
Astrazeneca Pharma India can be analyzed on the following key metrics -
- TTM P/E: 188.36
- Sector P/E: 30.97
- Dividend Yield: 0.29%
- D/E ratio: -
Astrazeneca Pharma India reported a net profit of 161.51 Cr in 2024.
The Mutual Fund Shareholding was 5.04% at the end of 31 Dec 2024.